Skip to main content

Indian Health Officials Asks J&J To Reveal Talc Contents

Indian Health Officials Asks J&J To Reveal Talc Contents

Indian Health Officials Asks J&J To Reveal Talc Contents

Introduction

Indian health officials are demanding a detailed list of the ingredients used in Johnson & Johnson's Baby Powder and other talc-based products due to concerns over the alleged carcinogenic asbestos presence in their products. India’s Central Drugs Standard Control Organization (CDSCO) sent out an email on July 19, requesting J&J to reveal the talcum powder contents.

Though in a March 2016 review, CDSOC cleared the company's products of asbestos presence during an inspection of a J&J manufacturing plant in Mumbai, the concerns sour high following a recent $4.7 billion verdict in a talcum trial in Missouri linked to ovarian cancer claims by 22 women.

Currently, there are two separate allegations against J&J, one regarding asbestos presence in their talc-based products causing ovarian cancer in women using it for personal hygiene purpose and the other linked to asbestos exposure causing mesothelioma, a fatal lung cancer. However, J&J continues to deny that their talcum products contain cancer-causing asbestos in them and plans to appeal all the jury verdicts against them.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!